We are live on
!
Find out more
MSDF
Michael & Susan Dell Foundation Portfolio holdings
AUM
$2.85B
1-Year Est. Return
26.28%
This Fund
S&P 500
This Quarter
Est. Return
-6.28%
1 Year Est. Return
+26.28%
3 Year Est. Return
+120.2%
5 Year Est. Return
+106.5%
10 Year Est. Return
–
AUM
$103M
AUM Growth
-$14.5M
(-12%)
Cap. Flow
+$234K
Cap. Flow
% of AUM
0.23%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$5.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$4.88M |
| 2 |
Alaunos Therapeutics
TCRT
|
+$122K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 49.64% |
| 2 | Real Estate | 27.16% |
| 3 | Healthcare | 23.2% |
Similar funds
WG
MWM
YC
SAI
AHSSHC
AIP
CAM
GS
Michael & Susan Dell Foundation's Q1 2016 Portfolio in Review
As of Q1 2016, Michael & Susan Dell Foundation held 8 positions worth $103M, down 12% from $117M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Michael & Susan Dell Foundation's Q1 2016 filing shows 1 new and 2 reduced positions. Its largest new stake was Berkshire Hathaway Class B: 39,500 shares worth $5.6M. The largest sale was Endo International plc, an estimated $4.88M.
By sector, the portfolio is most concentrated in Financials at 50% of assets, up from 43% a quarter earlier, followed by Real Estate and Healthcare.
- Michael & Susan Dell Foundation's largest Q1 2016 buy was Berkshire Hathaway Class B: 39,500 shares worth $5.6M.
- Michael & Susan Dell Foundation's biggest Q1 2016 reduction was Endo International plc, cutting an estimated $4.88M.
- Michael & Susan Dell Foundation's ten largest holdings make up 100% of its $103M portfolio in Q1 2016.
- Michael & Susan Dell Foundation opened 1 new position and closed 0 in Q1 2016.
- Michael & Susan Dell Foundation's portfolio value fell 12% quarter-over-quarter to $103M.
Based on Michael & Susan Dell Foundation's 13F filing for Q1 2016, filed 16 May 2016.